Authors: CZUWARA J NOWICKA U UHRYNOWSKA I GACLONG Z OLSZEWSKA M MAJEWSKI S JABLONSKA S BLASZCZYK M RUDNICKA L

Citation: J. Czuwara et al., THE EFFECT OF TOPOISOMERASE-I INHIBITOR CAMPTOTHECIN ON EXPRESSION OFP53 IN SCLERODERMA FIBROBLASTS, Journal of investigative dermatology, 110(4), 1998, pp. 596-596

Authors: UHRYNOWSKA IA CZUWARA J NOWICKA U GACLONG Z OLSZEWSKA M MAJEWSKI S JABLONSKA S BLASZOZYK M RUDNICKA L

Citation: Ia. Uhrynowska et al., PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH SYSTEMIC-SCLEROSIS SHOW ABNORMALLY HIGH EXPRESSION OF PROLACTIN, Journal of investigative dermatology, 110(4), 1998, pp. 656-656

Authors: RUDNICKA L MAKIELA B MAJEWSKI S CZUWARA J NOWICKA U BARUSINSKA A JABLONSKA S

Citation: L. Rudnicka et al., REGULATION OF TOPOISOMERASE-I EXPRESSION AND ACTIVITY IN DERMAL FIBROBLASTS, Journal of investigative dermatology, 106(4), 1996, pp. 745-745

Authors: MAKIELA B BARUSINSKA A CZUWARA J MAJEWSKI S JABLONSKA S RUDNICKA L

Citation: B. Makiela et al., THE EFFECT OF CAMPTOTHECIN, AN APOPTOSIS-INDUCING FACTOR, ON PROLIFERATION AND ACTIVITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN PATIENTS WITH SYSTEMIC-SCLEROSIS, Journal of investigative dermatology, 104(4), 1995, pp. 652-652